Development and evaluation of acyclovir loaded chitosan microspheres and cross linked with glutaraldehyde
Abstract
The guanine derivative antiviral drug acyclovir (ACV) is one of the oldest molecules put downing triumphant market until date, being commercially accessible in a variety of dosage forms for oral, topical and parenteral administrations. Clinical purpose of this drug is better to new antiviral agents due to its potential values such as suppression of recurrence, security profile, negligible drug interactions and being inexpensive. ACV is slightly water soluble, less permeable and poorly bioavailable, yet further potential antiviral molecule, the physicochemical alterations and new dosage form approaches resulted with more than 100 research efforts within a decade. The current study endeavored at the formulation of chitosan microspheres loaded with ACV to conquer the poor bioavailability and recurrent dose administration. Chitosan microspheres were prepared by emulsification technique by glutaraldehyde cross-linking. A variety of formulation and process variables such as polymer, glutaraldehyde, drug, span 80 concentrations, effect of stirring speed and stirring time were optimized. Formulated microspheres were characterized for its drug loading, invitro drug release, entrapment efficiency, surface morphology (SEM), particle size analysis and FTIR spectroscopy. The characterization of the fabricated microspheres demonstrated smooth surface with thin particle size allocation and entrapment efficiency of 80.8% for stirring speed batch. The prepared microspheres showed a controlled drug release of 93.2% over a period of 8 hrs with initial burst release of 56.7 % in the first 2hrs. The FTIR showed that there was no possible drug interaction among the drug and polymer. From the data’s obtained it can be concluded that the chitosan microspheres could be believed as a possible carrier for controlled drug delivery of ACV.
Keywords: Acyclovir, Antiviral drug, Microspheres, Chitosan, Glutaraldehyde.
Keywords:
Acyclovir, Antiviral drug, Microspheres, Chitosan, GlutaraldehydeDOI
https://doi.org/10.22270/jddt.v11i5.5123References
Anil G, Satyanarayana T, Suresh Kumar P, Pavani S. Formulation and evaluation of gastroretentive floating tablets of Venlafaxine hydrochloride. Int J Pharm Ind Res 2011; 1:76-84.
Bindu MB, Zulkar NK, Ramalingam R, Ravindernath A, Kusum B, Naga MM, et al., Formulation and evaluation of mucoadhesive microspheres of venlafaxine hydrochloride. J Pharm Res 2010; 3(11):2597-2600.
Parmar H, Bakliwal S, Gujarathi N, Pawar S.Different methods of formulation and evaluation of mucoadhesive microsphere. Int J App Bio Pharma Tech 2010; 3(3):1157-1167.
Velmurugana S,Ali M. Formulation and evaluation of maraviroc mucoadhesive microsheres by ionotropic gelation method. Int J Pharm Sci 2013; 5(4):294-302.
Learoyd TP, Burrows JL, French E, Seville PC. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur J Pharm Biopharm 2008; 68:224-34. https://doi.org/10.1016/j.ejpb.2007.04.017
De Miranda P, Blum MR. J Antimicrob Chemother 1983; 12:29-37. https://doi.org/10.1093/jac/12.suppl_B.29
De Miranda P, Krasny HC, Page DA, Elion GB. J Pharmacol Exp Ther 1981; 219:309-315.
Jameela SR, Jayakrishnan A. Glutaraldehyde cross linked chitosan microspheres as a long acting biodegradable drug delivery vehicle; Studies on the in vitro release of mitoxanthrone and in vivo degradation of microspheres in rat muscle. Biomaterials 1995; 16(10):769-775. https://doi.org/10.1016/0142-9612(95)99639-4
Patel JK, Patel MM. Stomach specific anti- helicobacter pylori therapy: preparation and evaluation of amoxicillin loaded chitosan mucoadhesive microspheres. Curr Drug Deliv2007; 4:41-50. https://doi.org/10.2174/156720107779314811
Thanoo C, Sunny MC, Jayakrishnan A. Oral sustained release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid. J Pharm Pharmacrol 1993; 45:21-4. https://doi.org/10.1111/j.2042-7158.1993.tb03672.x
Jaimini M, Rana AC, Tanwar YS. Formulation & evaluation of famotidine floating tablets. Curr Drug Deliv 2007; 4:51-55. https://doi.org/10.2174/156720107779314730
Published
Abstract Display: 687 
PDF Downloads: 603 PDF Downloads: 60 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.